Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Chrysanthemum zawadskii extract may help treat hair loss by promoting hair growth and affecting growth factors.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Exercise improves insulin sensitivity and hormone regulation in PCOS rats.

The normal human prostate does not significantly affect blood DHT levels.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

The compound 16 from the Merremia peltata plant could potentially be a good treatment for hair loss (alopecia) due to its strong activity and favorable skin absorption.

More research is needed to understand how testosterone is maintained in adult males.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Higher DHT in male baldness may protect against prostate cancer.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Menopause affects hair and skin; more research needed for treatment.

Arctiin helps protect hair cells from damage and death caused by oxidative stress.

No link found between new male baldness genes and female hair loss.